Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL2345977

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition of B-Raf V600E mutant in human SK-MEL-28 cells assessed as decrease in ERK phosphorylation incubated for 1 hr by immunoassay
12
Total Activities
12
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Cell Type SK-MEL-28
Confidence 9 — Direct single protein target
Curated By Autocuration

Target

Serine/threonine-protein kinase B-raf (CHEMBL5145)
Type SINGLE PROTEIN
Organism Homo sapiens

Publication

Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors.
Rheault TR, Stellwagen JC, Adjabeng GM, Hornberger KR, Petrov KG, Waterson AG, Dickerson SH, Mook RA, Laquerre SG, King AJ, Rossanese OW, Arnone MR, Smitheman KN, Kane-Carson LS, Han C, Moorthy GS, Moss KG, Uehling DE.
ACS Med Chem Lett (2013) 4 : 358 -362
PubMed 24900673 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 12 7.58 8.40

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL2028663 DABRAFENIB 4.0 1 8.40
CHEMBL2337915 1 8.40
CHEMBL2337916 1 8.15
CHEMBL2337910 1 8.15
CHEMBL2337917 1 7.96
CHEMBL1808262 1 7.64
CHEMBL2337913 1 7.58
CHEMBL2337912 1 7.55
CHEMBL2331621 1 7.29
CHEMBL2337914 1 7.14
CHEMBL2337909 1 7.11
CHEMBL2337911 1 5.59

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL2028663 DABRAFENIB IC50 = 4.0 nM 8.40
CHEMBL2337915 IC50 = 4.0 nM 8.40
CHEMBL2337916 IC50 = 7.0 nM 8.15
CHEMBL2337910 IC50 = 7.0 nM 8.15
CHEMBL2337917 IC50 = 11.0 nM 7.96
CHEMBL1808262 IC50 = 23.0 nM 7.64
CHEMBL2337913 IC50 = 26.0 nM 7.58
CHEMBL2337912 IC50 = 28.0 nM 7.55
CHEMBL2331621 IC50 = 51.0 nM 7.29
CHEMBL2337914 IC50 = 73.0 nM 7.14
CHEMBL2337909 IC50 = 78.0 nM 7.11
CHEMBL2337911 IC50 = 2555.0 nM 5.59